“…Native BK channels exhibit a wide range of biophysical, pharmacological, and functional properties that differ among various cell types (Ding, Li, & Lingle, 1998; Gessner et al, 2005; Jones, Gray-Keller, Art, & Fettiplace, 1999; Xia, Ding, & Lingle, 1999), at different stages of development (Carvalho-de-Souza, Varanda, Tostes, & Chignalia, 2013), and in different physiological or pathological conditions (Hu et al, 2011; Manzanares et al, 2015; Tao et al, 2015). BK channels with slightly different biophysical properties can be produced by alternative splicing of KCNMA1 precursor mRNA at several different sites (Glauser, Johnson, Aldrich, & Goodman, 2011; Ramanathan, Michael, Jiang, Hiel, & Fuchs, 1999; Saito, Nelson, Salkoff, & Lingle, 1997; Schreiber, Yuan, & Salkoff, 1999; Yu, Upadhyaya, & Atkinson, 2006).…”